Synthetic fibrinolytic agents. 2. Selected N-monosubstituted bis(tetrahydroisoquinolines) designed to possess enhanced bioavailability.
D000284:Administration, Oral; D000818:Animals; D001682:Biological Availability; D001777:Blood Coagulation / Q000187:drug effects; D004353:Drug Evaluation, Preclinical; D005342:Fibrinolysis / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000138:chemical synthesis* / Q000494:pharmacology; D007546:Isoquinolines / Q000008:administration & dosage / Q000138:chemical synthesis* / Q000494:pharmacology; D008297:Male; D011409:Propylene Glycols; D051381:Rats; D013329:Structure-Activity Relationship
D005343:Fibrinolytic Agents; D007546:Isoquinolines; D011409:Propylene Glycols